Current problems and recent advances in the molecular diagnosis of genital human papillomavirus infections;Genital ̄nsan Papillomavirus Enfeksiyonlarinin Moleküler Tanisinda Karşilaşilan Sorunlar ve Yeni Gelişmeler

Mikrobiyoloji Bulteni

Volumn 48, Issue 4, 2014, Pages 689-706

  Şahiner, Fatih ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Genital infection; Genotyping; HPV; Human papillomavims; Molecular diagnosis; Screening test

Indexed keywords

VIRUS DNA;

COMPLICATION; GENETIC PROCEDURES; GENETICS; GENOTYPING TECHNIQUE; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCTIVE TRACT INFECTIONS; STANDARDS; UROGENITAL TRACT TUMOR; VIROLOGY;

DNA, VIRAL; GENETIC TECHNIQUES; GENOTYPING TECHNIQUES; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRODUCTIVE TRACT INFECTIONS; UROGENITAL NEOPLASMS;

EID: 84916638934     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: 10.5578/mb.7631     Document Type: Review

References (59)

1. Şahiner F, Gümral R. Human papillomavirus enfeksiyonlan ve ilişkili kanserler. FLORA 2012;17(3):93-102.
2. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348(6):518-27.
3. Şahiner F, Şener K. Human papilloma virus enfeksiyonlari, risk faktörleri ve koruyucu önlemler. TSK Koruyucu Hekimlik Bülteni 2013;12(6):715-22.
4. Lenhoff A. Five FDA-approved HPV assays. MLO Med Lab Obs 2012;44(7):14, 16, 18.
5. Şahiner F, Kubar A, Yapar M, Şener K, Dede M, Gümral R. Detection of major HPVs by a new multiplex realtime PCR assay using type-specific primers. J Microbiol Methods 2014;97:44-50.
6. Nindl I, Rindfleisch K, Lotz B, Schneider A, Dürst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999;82(2):203-7.
7. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38(1):357-61.
8. Gravitt PE, Viscidi RP. Measurement of exposure to human papillomaviruses, pp: 119-41. In: Rohan TE, Shah KV (eds), Cervical Cancer: From Etiology to Prevention. 2004, Kluwer Academic Publishers, Boston.
9. Depuydt CE, Boulet CA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 2007;11(4):881-91.
10. Poljak M, Kocjan BJ. Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Rev Anti Infect Ther 2010;8(10):1139-62.
11. Dutra I, Foroni I, Couto AR, Lima M, Bruges-Armas J. Molecular diagnosis of human papillomavirus, pp: 203-46. In: Vanden Broeck D (ed), Human Papillomavirus and Related Diseases - From Bench to Bedside - Research Aspects. 2012, InTech, Rijeka, Croatia.
12. Bauer HM, Greer CE, Manos MM. Determination of genital HPV infection using consensus PCR, pp: 131-52. In: Herrington CS, McGee JO'D (eds), Diagnostic Molecular Pathology: A Practical Approach. 1992, Oxford University Press, Oxford, UK.
13. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76(Pt 4):1057-62.
14. Lee JH, Lee NW, Hong SW, Nam YS, Choi JW, Kim YS. Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II. Cytopathology 2011;22(4):261-8.
15. Şahiner F, Gümral R, Şener K, Yiʇit N, Dede M, Yapar M, Kubar A. Servikal sürüntü örneklerinde iki farkli yöntemle HPV-DNA varliʇinin araştirilmasi: MY09/11 konsensus PCR ve tipe özgül gerçek zamanli PCR. Mikrobiyol Bul 2012;46(4):624-36.
16. Eder PS, Lou J, Huff J, Macioszek J. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform. J Clin Virol 2009;45(Suppl 1):S85-92.
17. Molijn A, Kleter B, Quint W, van Doom LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005;32(Suppl 1):S43-51.
18. Stillman MJ, Day SP, Schutzbank TE. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus. J Clin Virol 2009;45(Suppl 1):S73-7.
19. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006;44(2):504-12.
20. Takács T, Jeney C, Kovács L, Mózes J, Benczik M, Sebe A. Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types. J Virol Methods 2008;149(1):153-62.
21. Gillio-Tos A, De Marco L, Ghisetti V, et al. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J Clin Virol 2006;36(2):126-32.
22. Cuzick J, Mayrand MH, Ronco G, Snijders P, Wardle J. Chapter 10: New dimensions in cervical cancer screening. Vaccine 2006;24(Suppl 3):S3/90-7.
23. Lambert PF, Collins A. Papillomaviruses: Molecular biology of human viruses, pp: 18-26. In: Mahy BWJ, Van Regenmortel MHV (eds), Encyclopedia of Virology. 2008, 3rd ed. Academic Press, Oxford, England.
24. Luevano M, Bernard HU, Barrera-Saldana HA, et al. High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology 2010;405(1):31-40.
25. Molden T, Kraus I, Skomedal H, Nordstrom T, Karisen F. PreTectTM HPV-Proofer: Real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 2007;142(1-2):204-12.
26. Kleter B, van Doom LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37(8):2508-17.
27. Handricks DA, Comanor L. Signal amplification-based techniques, pp: 19-64. In: Lorincz A (ed), Nucleic Acid Testing for Human Disease. 2006. CRC/Taylor & Francis, New York.
28. Malloy C, Sherris J, Herdman C. HPV DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-Resource Settings. PATH, 2000. Available at: http://screening.iarc.fr/doc/HPV-DNA-Testing-lssues.pdf
29. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9(10):929-36.
30. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41(7):3221-8.
31. Fuessel Haws AL, He Q, Rady PL, et al. Nested PCR with the PGMY09/11 and GP5 (+)/6 (+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods 2004;122(1):87-93.
32. Harnish DC, Belland LM, Scheid EE, Rohan TE. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction. Mol Cell Probes 1999;13(1):9-21.
33. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990;71(Pt 1):173-81.
34. Evander M, Edlund K, Bodén E, et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol 1992;30(4):987-92.
35. Strauss S, Jordens JZ, Desselberger U, Gray JJ. Single-tube real-time nested polymerase chain reaction for detecting human papillomavirus DNA. Diagn Mol Pathol 2000;9(3):151-7.
36. van Alewijk D, Kleter B, Vent M, et al. A human papilloma virus testing algorithm comprising a combination of the LI broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay. J Clin Microbiol 2013;51(4):1171-8.
37. Morris BJ. Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region. Clin Chem Lab Med 2005;43(11):1171-7.
38. Cañadas MP, Darwich L, Sirera G, et al; HIV-HPV Can Ruti Study Group. Human papillomavirus 16 integration and risk factors associated in anal samples of HIV-1 infected men. Sex Transm Dis 2010;37(5):311-5.
39. Tang N, Huang S, Erickson B, et al. High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott Real Time High Risk HPV test. J Clin Virol 2009;45(Suppl 1):S25-8.
40. Kocjan BJ, Seme K, Poljak M. Comparison of the Abbott Real Time High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. J Virol Methods 2011;175(1):117-9.
41. Kay P, Meehan K, Williamson AL. The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA. J Virol Methods 2002;105(1):159-70.
42. Vernon SD, Linger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000;38(2):651-5.
43. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36(10):3020-7.
44. van Hamont D, van Ham MA, Bakkers JM, Massuger LF, Melchers WJ. Evaluation of the SPF10-INNO L̄PA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J Clin Microbiol 2006;44(9):3122-9.
45. Klaassen CH, Prinsen CF, de Valk HA, Horrevorts AM, Jeunink MA, Thunnissen FB. DNA microarray format for detection and subtyping of human papillomavirus. J Clin Microbiol 2004;42(5):2152-60.
46. Park TC, Kim CJ, Koh YM, et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol 2004;23(2):119-25.
47. Andersson S, Hansson B, Norman I, et al. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a. Int J Oncol 2006;29(3):705-11.
48. Jeantet D, Schwarzmann F, Tromp J, et al. NucliSENS EasyQ HPV vl test - Testing for oncogenic activity of human papillomaviruses. J Clin Virol 2009;45(Suppl 1):S29-37.
49. Getman D, Aiyer A, Dockter J, Giachetti, C, Zhang F, Ginocchio CC. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets. J Clin Virol 2009;4(Suppl 1):S49-54.
50. Dockter J, Schroder A, Eaton B, et al. Analytical characterization of the APTIMA HPV Assay. J Clin Virol 2009;45(Suppl 1):S39-47.
51. Cuzick J, Cadman L, Mesher D, et al. Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer 2013;108(4):908-13.
52. Lamarcq L, Deeds J, Ginzinger D, Perry J, Padmanabha S, Smith-McCune K. Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening. J Mol Diagn 2002;4(2):97-102.
53. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002;94(8):2199-210.
54. Sotlar K, Selinka HC, Menton M, Kandolf R, Bültmann B. Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol 1998;69(2):114-21.
55. Cornelissen MT, Smits HL, Briet MA, et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol 1990;71(Pt 5):1243-6.
56. Peitsaro P, Johansson B, Syrjánen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40(3):886-91.
57. Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999;59(24):6132-6.
58. Luft F, Klaes R, Nees M, et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001;92(1):9-17.
59. Hong SP, Shin SK, Lee EH, et al. High-resolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nat Protoc 2008;3(9):1476-84.